Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IND SWIFT LA Gains 20%; BSE HEALTHCARE Index Up 1.1%
Wed, 31 Jul 14:5

IND SWIFT LA Gains 20%; BSE HEALTHCARE Index Up 1.1%Image source: Kameleon007 /www.istockphoto.com

IND SWIFT LA share price has zoomed 20% and is presently trading at Rs 166.4.

Meanwhile, the BSE HEALTHCARE index is at 40,597.4 (up 1.1%).

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 7.5%) and AJANTA PHARMA (up 7.3%).

POLY MEDICURE (down 4.3%) and NARAYANA HRUDAYALAYA (down 1.6%) are among the top losers today.

Over the last one year, IND SWIFT LA has moved up from Rs 97.1 to Rs 166.4, registering a gain of Rs 69.3 (up 71.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,597.4, registering a gain of 46.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 105.8%), Jubilant Pharmova (up 105.3%) and Cadila Healthcare (up 97.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,664.1 (up 0.3%).

The top gainers among the BSE Sensex today are Asian Paints (up 2.6%) and JSW Steel (up 2.4%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,934.3 (up 0.3%). HDFC LIFE INSURANCE and Asian Paints are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,664.1, registering a gain of 15,136.4 points (up 22.8%).

IND SWIFT LA Financial Update...

IND SWIFT LA net profit grew 1053.7% YoY to Rs 2,389 million for the quarter ended March 2024, compared to a loss of Rs 250 million a year ago. Net sales rose 29.3% to Rs 3,933 million during the period as against Rs 3,042 million in January-March 2023.

For the year ended March 2023, IND SWIFT LA reported 2325.7% increase in net profit to Rs 478 million compared to net loss of Rs 21 million during FY22. Revenue of the company grew 16.2% to Rs 12,073 million during FY23.

The current Price to earnings ratio of IND SWIFT LA, based on rolling 12 month earnings, stands at 3.2.


Equitymaster requests your view! Post a comment on "IND SWIFT LA Gains 20%; BSE HEALTHCARE Index Up 1.1%". Click here!